Position
Squarepoint Ops LLC in Syndax Pharmaceuticals Inc
Back to the book · All holders of SNDX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $46.6K$21.01 → $23.36
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 19.8K | $416.3K | — | — | — | 0.0% |
| Q1 2026 | 181.6K | $4.24M | $23.36 | $46.6K | $3.78M | 0.0% |